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A distinctive mechanism of cell injury during ATP depletion involves the loss of cellular
glycine. The current study examined whether provision of glycine during ATP depletion can
prevent injury in PC-12 cells, a cell line with neuronal property. In addition, we have examined
the role played by glycine receptors in cytoprotective effects of the amino acid. It was shown
that ATP depletion led to plasma membrane damage in PC-12 cells, which was ameliorated by
0.25–5mM glycine. Cytoprotective activity of glycine was shared by alanine, but not by gluta-
mate or -aminobutyric acid (GABA). Of interest, strychnine, an antagonist of glycine recep-
tor, was also protective. The results, while suggesting the involvement of glycine receptor in
cytoprotection, indicate that chloride channel activity of the receptor is dispensable. Such a sce-
nario is further supported by the observation that removal of extracellular chloride did not affect
ATP depletion–induced cell injury or its prevention by glycine. In short, this study has provided
the first evidence for glycine protection of cells with neuronal properties. Cytoprotection may
involve the glycine receptor; however, it can be dissociated from its channel activity.
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INTRODUCTION
Ischemic diseases, including myocardial infarc-
tion, acute renal failure, and stroke in the brain, are
main causes of morbidity and mortality in industrial
countries. As a result of the decreased blood flow,
cells in ischemic tissues are depleted of oxygen and
metabolic nutrients, and lose their capacity for ATP
production and become energy deprived. When cell
ATP falls to a level that is inadequate to sustain cellu-
lar homeostasis, destructive processes are activated,
culminating in cell injury and death (1–6).
Cell injury resulting from ATP depletion is me-
diated by multiple factors. Intracellular Ca2 over-
load has long been recognized as a destructive event
in ATP-depleted cells (7,8). Generation of free radi-
cals has been documented in vivo during organ is-
chemia, as well as in vitro models of ATP depletion
(9–11). Moreover, activation of hydrolytic enzymes,
including DNases, phospholipases, and proteases, has
been shown in ATP-depleted cells and is expected to
execute the cells at the molecular level (5,6,12). In
addition to these observations, recent studies have
documented yet another mechanism that underlies
cell injury by ATP depletion (13). This distinctive
mechanism involves the loss of glycine from ATP-
depleted cells, followed by plasma membrane break-
down, leakage of cytosol, and cell death by necrosis
(14). Of significance, this type of injury is com-
pletely diminished by the presence of 0.25–1 mM
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glycine (13–17). In vivo, glycine has been shown to
diminish tissue damage in ischemic organs including
liver, intestine, and kidneys (18–23).
Despite these studies, there is no report on glycine
protection of cells of neuronal origin or from the nerv-
ous system. Investigation of glycine effects in neuronal
cells is further justified by the potential involvement of
glycine receptors in the cytoprotective action of the
amino acid (24–26). Glycine-sensitive injury in ATP-
depleted cells has been defined as proteinaceous pores in
the plasma membrane (16). In addition, pharmacological
evidence suggests that development of the porous de-
fects may be related to glycine receptors (24–26). To
date, glycine receptors have been identified only in
nervous systems (27). Examination of glycine protection
in neuronal cells may therefore lay a background for pur-
suing the role of classical glycine receptors in cyto-
protection by this amino acid.
With these considerations, we have examined the
effects of glycine on ATP depletion–induced injury in
PC-12 cells. Originally isolated from rat adrenal
pheochromocytoma, PC-12 cells exhibit characteris-
tics of neurons, including neurotransmitter secretion,
electrical excitability, and neurite extension after
nerve growth factor stimulation, and therefore have
been widely used in neurobiological research (28–30).
This study was designed to answer two specific ques-
tions: (i) does glycine protect PC-12 cells against cell
injury resulting from ATP depletion; and (ii) is the
glycine effect dependent on the activity of glycine-
gated chloride channels? In other words, does glycine
protect ATP-depleted cells through its regulation of
chloride fluxes? Our results show that ATP depletion
led to plasma membrane damage in PC-12 cells. This
type of injury was significantly suppressed by glycine.
Of interest, the glycine-receptor antagonist strychnine
inhibited cell injury under ATP depletion as well.
Moreover, when extracellular chloride was completely
removed, cell injury and the protective effects of
glycine were not modified. The results suggest that
glycine protection is independent of the channel activ-
ity of glycine receptors and may be dissociated from
chloride fluxes in ATP-depleted cells.
EXPERIMENTAL PROCEDURE
Cell Culture. PC-12 cells were purchased from American Type
Culture Collection (ATCC, Rockville, MD) and maintained in RPMI
medium 1640 containing 10% heat-inactivated horse serum and 5%
fetal bovine serum. The cultures were split every 4 days. Flasks and
dishes for cell culture were coated with collagen. For experiment,
cells were seeded at 0.25  106/well of 12-well plate and used after
overnight growth.
ATP Depletion. Cells were rinsed twice with phosphate-
buffered saline to remove culture medium. For experimental groups,
cells were then transferred to glucose-free Krebs-Ringer bicarbon-
ate solution (composition in mM: 115 NaCl, 3.5 KCl, 25 NaHCO3,
1 KH2PO4, 1.25 CaCl2, and 1 MgSO4; gassed with 5% CO2). Car-
bonyl cyanide-m-chlorophenyl hydrazone (CCCP, 15 M), a mito-
chondrial uncoupler, was added to the incubation solution to block
ATP production. Free Ca2 in the medium was buffered to 100 nM
with 2.25 mM EGTA (31). The Ca2 ionophore ionomycin was
included in the buffer at 5 M so that the cells were permeabilized
to Ca2, and intracellular free Ca2 was clamped at extracellular
levels (32,33). Clamping of intracellular free Ca2 at 100 nM during
ATP depletion minimizes Ca2-dependent injury and facilitates the
examination of cytoprotective effects of glycine (16,33). For control
groups, cells were incubated in glucose-free Krebs-Ringer bicar-
bonate solution with 100 nM Ca2.
Measurement of LDH Release from Cells. Lactate dehydro-
genase (LDH) is a cytosolic protein with a molecular weight of
136 kD. When plasma membranes of cells are broken, LDH is
released into the incubation medium. We therefore measured cellu-
lar LDH release to indicate the breakdown of plasma membranes
and cell injury. LDH was measured as the enzymatic activity cata-
lyzing the reaction: pyruvate  NADH  lactate  NAD. NADH
exhibits fluorescence at an excitation wavelength of 360 nm with
emission at 450 nm. The velocity of decreases in Ex 360 nm/Em 450
nm fluorescence in the reaction indicates the conversion of NADH
to the nonfluorescent NAD, therefore LDH activity. At the end of
cell incubation, 100 l of medium was subjected to brief centri-
fugation to remove cellular debris. Supernatant was added to 2.5 ml
enzymatic reaction buffer (0.2 M potassium phosphate buffer, pH
7.5) containing 6 mM pyruvate and 0.02 mM NADH. Velocity of
decreases in fluorescence at Ex 360 nm/Em 450 nm was monitored
on an LS-3 fluorescence Spectrophotometer (Perkin-Elmer) to indi-
cate LDH activity. Parallel dishes of cells were lysed with 0.1%
Triton X-100 to determine total LDH activity. The LDH activity
obtained from cell incubation medium was divided by the total LDH
activity to calculate the percentage of LDH release.
Chemical Analyses. To measure ATP, cells were extracted
with trichloroacetic acid. ATP in cell extracts was measured by
luminometry of the luciferin firefly luciferase reaction (17,25). ATP
values were expressed as nanomole per milligram of cell protein.
Protein was quantitated with the bicinchoninic acid (BCA) reagent
purchased from Pierce Chemical Company (Rockford, IL, USA).
RESULTS
Plasma Membrane Damage in PC-12 Cells In-
duced by ATP Depletion. In mammalian cells, there
are two major pathways for ATP generation, oxidative
phosphorylation via electron transport in the mito-
chondrion and anaerobic glycolysis in the cytosol. To
induce ATP depletion, we incubated PC-12 cells with
a physiological buffer that was free of glucose, the
glycolytic substrate, to eliminate ATP generation
through glycolysis. Moreover, CCCP, a mitochondrial
uncoupler was included in the incubation medium to
block ATP production through oxidative phosphory-
lation. Under these conditions, rapid declines of cellu-
lar ATP were observed. As shown in Fig. 1A, within
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Fig. 1. ATP depletion–induced plasma membrane breakdown in PC-12 cells. A, Time course of ATP depletion in PC-12 cells induced by CCCP
in glucose-free medium. Cell ATP declined rapidly after CCCP exposure. B, Release of cellular LDH into incubation medium during ATP de-
pletion. ATP depletion led to plasma membrane damage, shown here as the release of cytosol LDH. C, ATP levels in PC-12 cells after 6 h of
CCCP incubation in the absence or presence of 1 mg/ml glucose. Glucose facilitated ATP production through glycolysis in CCCP-treated cells
and maintained cellular ATP to 60% of control. D, LDH release from CCCP-treated PC-12 cells in the absence or presence of glucose. Glu-
cose, while maintaining cell ATP, prevented cell injury or LDH release during CCCP incubation. Values shown in this figure are mean  SD
(n  3).
15 min, ATP levels in treated cells decreased to less
than 10% of control. At the end of 1 h of incubation,
only a trace amount of cellular ATP was detected.
ATP-depleted cells developed plasma membrane dam-
age, as indicated by the leakage of LDH, a cytosolic
protein of 136,000 D (Fig. 1B). After 3 h of ATP de-
pletion, over 30% of cells lost the integrity of their
plasma membranes, leaking LDH. As the incubation
was prolonged, more cells were damaged and became
permeable to macromolecules. By the end of 6 h of
ATP depletion, over 60% of cells leaked LDH (Fig.
1B). Cell injury under these conditions was dependent
on ATP depletion. As shown in Fig. 1C, glucose pro-
vided during CCCP treatment maintained cellular ATP
at substantial levels. This was accompanied by the pre-
vention of plasma membrane damage or LDH release
(Fig. 1D).
Protection of ATP-Depleted PC-12 Cells by
Glycine. To examine the effects of glycine on cell
injury in PC-12 cells, we initially compared LDH
release induced by ATP-depletion, in the presence or
absence of 5 mM glycine. The results are shown in
Fig. 2A. The time control group that was incubated in
glucose-free medium without CCCP exposure had
13% LDH release. After 6 h of ATP depletion, almost
70% of cells lost their LDH into the incubation
medium (Fig. 2A, CCCP-glycine). When 5 mM gly-
cine was provided during ATP depletion, LDH re-
lease was drastically reduced to 25% (Fig. 2A, CCCP 
glycine), indicating cytoprotection offered by this
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amino acid. Glycine protection was also detected
after longer periods of ATP depletion (not shown).
Dose dependence of glycine protection is shown in
Fig. 2B. Glycine at 0.1 mM already had slight pro-
tective effects, while evident protection was shown
at concentrations of 0.25 mM or above. Maximal
protection was achieved at glycine concentrations of
1–5 mM.
Glycine protection was associated with increased
survival of the cells. As shown in Fig. 2C, without
glycine, less than 5% of cells were viable 24 h after
ATP depletion. On the contrary, over 20% of cells re-
covered after ATP depletion, when protected by
glycine. Of note, there was a significant difference be-
tween viability measurements using LDH release or
cell survival as parameters. For example, 25% LDH
release was shown for glycine protected cells (Fig.
2A), indicating cell viability of 75%. However, the
survival rate for this group of cells was only 23% (Fig.
2C). There were at least two possibilities to account
for the differences. First, some of the cells that did not
leak LDH might have been injured not at the plasma
membrane level but at other critical sites, including
DNA breakdown. Second, cells detached during ATP
Fig. 2. Cytoprotective effects of glycine during ATP depletion of PC-12 cells. A, LDH release from ATP-depleted cells in the absence or pres-
ence glycine. Glycine at 5 mM reduced LDH release during 6 h of ATP depletion from 70% to 25%. B, Dose dependence of glycine cytopro-
tective effects. C, Cell survival. PC-12 cells were depleted of ATP for 6 h in the presence of 0–5 mM glycine, and LDH release from these
groups of cells were measured to indicate cell injury. To determine cell survival, cells were collected after ATP depletion and washed twice
with culture medium. The cells were replated into culture dishes and viable cells were counted after 24 h of culture. Survival rate was expressed
as percent of cells that were subjected to ATP depletion. Values, mean  SD, were obtained from three separate experiments. Significant
protection was shown for glycine at concentrations of 0.25 mM or above.
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Fig. 3. Glycine does not preserve cell ATP during CCCP treatment
in glucose free medium. PC-12 cells were incubated for 0–6 h with
CCCP in glucose-free medium in the absence or presence of 5 mM
glycine. ATP in these two groups of cells was determined by lumi-
nometry of the luciferin firefly luciferase reaction. Values were av-
erages of three separate experiments; error bars (SD) were not
shown for clarity. ATP depletion was induced by CCCP, regardless
the presence or absence of glycine.
depletion regardless of the presence or absence of
glycine. To determine survival rates, the detached
cells were replated and cultured overnight. During re-
plating, some cells did not attach to the dish and ulti-
mately lost their viability.
Glycine also protected ATP depletion–induced
injury in differentiated PC-12 cells. For differentia-
tion, PC-12 cells were cultured in the presence of
nerve growth factor for 8–10 days. In a typical exper-
iment, control differentiated cells showed 1.9% LDH
release and ATP depletion increased LDH release to
66%. When 1 mM glycine was provided, only 8.4%
LDH release was detected.
Glycine Does Not Prevent ATP Declines in
CCCP-Treated PC-12 Cells. Our results have shown
impressive cytoprotective effects of glycine against
ATP depletion–induced injury in PC-12 cells. An ob-
vious question was: does glycine protect the cells by
maintaining cellular ATP? To answer this question, we
compared ATP levels in glycine-protected and unpro-
tected cells during CCCP incubation. The results are
shown in Fig. 3. After 15 min of CCCP incubation,
ATP levels declined to 12% and 9% of control in
glycine-protected and unprotected cells, respectively.
By the end of 1 h CCCP incubation, cellular ATP de-
clined to less than 2% of control, regardless of the
presence or absence of glycine. Only traces of ATP
were detected in these cells after longer CCCP treat-
ment (Fig. 3). These data indicate clearly that glycine
protected PC-12 cells without preserving cellular ATP.
Cytoprotective Action of Glycine Depends on
Structure of the Amino Acid. Glycine protection of
ATP-depleted cells appeared to depend on the molec-
ular structure of this amino acid. As shown in Fig. 4,
alanine, which has an additional methyl group to the
glycine moiety, was cytoprotective during ATP deple-
tion, but it was not as effective as glycine. Whereas
1 mM glycine lowered the LDH release from ATP-
depleted cells from 64% to 27%, 40% LDH release
was detected in the group with 1 mM alanine. Further
modification of the amino acid structure led to com-
plete loss of cytoprotective effects. For example, no
significant protection was shown for glutamate (not
shown) or -aminobutyric acid (GABA) (Fig. 4).
These results suggest that protective action of glycine
might be determined by its structure.
Protection of ATP-Depleted PC-12 Cells by
Strychnine. Our results suggest that glycine protec-
tion might be specific for the structure of small amino
acids (Fig. 4). This observation points to interactions
of the amino acids with molecular targets in the cells.
In nervous system, receptors for glycine have been
identified (27). These receptors, also known as
glycine-gated chloride channels, are pentameric pro-
teins in the plasma membranes, which upon glycine
binding transform into channels that are specifically
permeable to chloride (27). To test the involvement of
these receptors in glycine cytoprotection, we exam-
ined the effects of strychnine, a well-known antago-
nist of glycine receptors in the nervous system (27).
The results are shown in Fig. 5. ATP depletion for 6 h
Fig. 4. Alanine but not larger amino acids share the cytoprotective
action of glycine. PC-12 cells were depleted of ATP for 6 h in the
absence or presence of 1 mM glycine, alanine, or GABA. Values,
mean  SD, were obtained from three separate experiments. Sig-
nificant cytoprotective effects were shown for glycine and alanine
but not for GABA. Glutamate did not protect ATP-depleted PC-12
cells either (data not shown).
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led to 70% LDH release. In the presence of 1 mM
glycine, LDH release was reduced to 26%, confirming
our previous observations of cytoprotection by this
amino acid. Of interest, protection was also shown for
strychnine, the glycine receptor antagonist (Fig. 5).
As a matter of fact, strychnine showed significant pro-
tective effects at the concentration of 0.1 mM, a dose
at which glycine had only marginal effects (Fig. 2B).
Glycine is an agonist and strychnine an antagonist of
chloride-channel receptors; thus these results, while
suggesting the involvement of the receptor protein in
cytoprotection, indicate clearly that the cytoprotective
effects are not associated with channel activity of the
receptors.
Dissociation of Glycine Protection from Chloride
Flux. To further examine whether glycine protects
ATP-depleted cells through activating the chloride chan-
nels, we monitored cell injury and glycine protection
in chloride-free medium. In this medium, chloride was
completely replaced with gluconate, an anion that is
not permeable to chloride channels. The results are
shown in Fig. 6. Omission of chloride did not have sig-
nificant effects on cell injury induced by ATP deple-
tion. In regular chloride medium, ATP depletion for
6 h led to 70% LDH release and to 64% for cells in
chloride-free medium. Of significance, glycine pro-
tected ATP-depleted cells, regardless of the presence
or absence of chloride. With 1 mM glycine, LDH
release during 6 h ATP depletion was reduced to less
than 30%, in chloride-containing as well as chloride-
free media. These results suggest that cytoprotective
effect of glycine can be dissociated from chloride flux
through glycine-gated channels.
DISCUSSION
The current study has demonstrated cytoprotec-
tive effects of glycine against injury by ATP depletion
in PC-12 cells. To our knowledge, this is also the first
report on glycine protection of cells with neuronal
property or of neuronal origin. The protective activity
appears to be rather specific for the structure of small
amino acids and is lost in larger amino acids such as
glutamate or GABA. Of interest, similar protective ac-
tivity was shown for strychnine, an antagonist of
glycine receptors in the nervous system. Both glycine
and strychnine interact with neural chloride channel-
receptors; thus these results may suggest the involve-
ment of the receptor protein in cytoprotective activity
of these chemicals. On the other hand, glycine and
strychnine regulate channel activity of the receptors in
opposite directions and yet display similar cytoprotec-
tion. Thus the cytoprotection seems to be dissociated
from the channel activity of the receptor. Further ex-
periments showed clearly that removal of chloride did
not affect cell injury during ATP depletion and, of sig-
Fig. 5. Cytoprotective effects of strychnine during ATP depletion of
PC-12 cells. PC-12 cells were depleted of ATP for 6 h in the absence
or presence of 1 mM glycine or 0.1–1 mM strychnine. LDH release
from these cells was monitored to indicate cell injury. Values, mean 
SD, were obtained from three separate experiments. Strychnine
was shown to be cytoprotective at concentrations as low as 0.1 mM.
Fig. 6. Effects of Cl omission on ATP depletion–induced cell in-
jury and its prevention by glycine. PC-12 cells were depleted of
ATP for 6 h in medium containing regular (119.75 mM) Cl or in
Cl-free medium. In Cl-free medium, Cl was substituted with
gluconate. Glycine at 5 mM was added during ATP depletion to ex-
amine it protective effects in the presence or absence of Cl. Cell
injury (LDH release) was monitored as described in the Experimen-
tal Procedure section. Values, mean  SD, were obtained from three
separate experiments. Similar extents of cell injury and glycine pro-
tection were shown in ATP-depleted cells for media with or without
Cl.
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nificance, it did not interfere with glycine cytoprotec-
tion either. The results indicate that cytoprotective ef-
fects of glycine are dissociated from chloride influx,
providing additional support for the notion that the
glycine receptor may participate in cytoprotection in a
way that is independent of its channel activity.
Since the first demonstration of the protective ef-
fects of glycine, several hypotheses on glycine protec-
tion have been proposed and tested. It has been shown
that glycine does not help the cells generate or con-
serve ATP. Moreover, glycine does not protect ATP-
depleted cells by preservation of ion homeostasis,
modification of intracellular pH, stabilization of the
cytoskeleton, quenching of reactive oxygen species, or
inhibition of phospholipid hydrolysis (32,34–36). In
addition, glycine cytoprotection does not rely on me-
tabolism of the amino acid (37). On the other hand,
studies by us and others have shown that the protective
activity is shared by a family of closely related amino
acids and several neural chloride channel modulators,
including the antagonist strychnine (24–26,38). With
these observations, we proposed that glycine and the
related compounds may protect ATP-depleted cells by
low-affinity interactions with a multimeric channel
protein, destabilization of which may otherwise lead to
formation of pathological pores (25). Such porous de-
fects in plasma membranes of ATP-depleted cells have
been characterized by our recent studies (16). The
membrane defects were shown to evolve from small
pores permeable only to propidium iodide (668 D), be-
fore enlarging to become permeable to larger mole-
cules such as LDH. Glycine provided during ATP
depletion blocked the development of membranous
pores completely. Of importance, the glycine effect
could be mimicked by a cell-impermeant cross-linker
that was expected to tether the subunits of multimeric
proteins in the plasma membrane and prevent their
breakdown (16). Further studies showed that-cell im-
permeable strychnine derivatives were able to protect
kidney epithelial cells and hepatocytes (17). These
observations are consistent with the hypothesis that
glycine cytoprotection may depend on its interaction
with a multimeric protein target in the plasma mem-
branes that are related to neuronal glycine receptors.
Despite these studies, classical glycine receptors have
thus far been identified only in neuronal cells. The
demonstration of glycine protection of PC-12 cells in
this study may therefore lay a background for further
investigation of glycine receptors in cytoprotective
effects of the amino acid.
Results from this study suggest that, although
glycine receptors may be involved in cytoprotection
by glycine, channel activity of the receptor proteins
can be dissociated. The involvement of glycine recep-
tors is suggested by the observation that modulators of
the receptors, including strychnine, share the cytopro-
tective action of glycine. On the other hand, strychnine
opposite to glycine is a classical antagonist of neuronal
glycine receptors and is a potent inhibitor of their
channel activity. Cytoprotective effects of glycine and
strychnine as well suggest that, while glycine recep-
tors may be involved in cytoprotection, channel activ-
ity of the receptors is dispensable. The conclusion that
chloride channel activity of the receptors can be dis-
sociated is further suggested by the experiment of
chloride removal. Omission of chloride from incuba-
tion medium did not significantly alter cell injury by
ATP depletion or modify glycine protection (Fig. 6).
The loss of ion homeostasis, particularly intracel-
lular Ca2 increase, has been implicated in cell injury
under in vitro as well as in vivo conditions of ATP de-
pletion (7,8). However, the focus of this study is not
Ca2-dependent cell injury or its modification by
glycine. Instead, this study has employed a technique
of Ca2 “clamping” to tightly control intracellular
Ca2+ to a level of 100 nM to minimize Ca2-dependent
injury. This enables a full expression of glycine-
sensitive injury that is Ca2-independent (16). The
technique of intracellular Ca2 clamping has been
established in our previous studies (16,33). In this
technique, the Ca2 ionophore ionomycin is added to
the incubation medium at a concentration of 5 M.
This leads to specific permeabilization of the plasma
membrane to Ca2 and an equilibration of Ca2 be-
tween the intracellular and intercellular spaces. For
normal cells with ATP, it may take some time to reach
the equilibrium, because Ca2 can be pumped out of
the cell or sequestered into mitochondria and endo-
plasmic reticulum in an energy dependent manner.
However, in this study, cells were depleted of ATP and
lost their ability to actively maintain Ca2 homeosta-
sis. Under these conditions, rapid Ca2 equilibrations
across the plasma membrane have been demonstrated
in all cell types examined including MDCK epithelial
cells, BEC endothelial cells, and 3T3 fibroblasts (ref.
[33]; unpublished data). Based on these data, the in-
tracellular Ca2 in this study is expected to be clamped
at the extracellular level of 100 nM. This assumption
is supported by the observation of impressive cytopro-
tective effects of glycine in the current study; as shown
before, glycine alone cannot protect cells from damage
by uncontrollable increases of cellular Ca2 (25).
Finally, it should be pointed out that demonstration
of cytoprotective effects of glycine in neuronal cells
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in vitro does not necessarily suggest that similar beneficial
effects of glycine can be achieved during tissue ischemia
in the nervous system. First of all, nervous systems, in-
cluding the brain, are far more complex than the liver,
intestine, or kidneys, structurally as well as functionally.
Second, neuronal cells, as excitable as they are, possess
many unique properties, compared with hepatocytes or
epithelial or endothelial cells. In particular, glycine acts
as an agonist of glycine-gated chloride channels, but it
is also a potent ligand for NMDA-sensitive glutamate
receptors (for a review see [39]). At low micromolar
concentrations, glycine binds to NMDA receptors and
behaves as a coagonist. At millimolar concentrations,
glycine reportedly can activate NMDA receptors by it-
self. Under these conditions, glycine may exhibit neuro-
toxicity, presumably through its activation of NMDA
receptor channels followed by Ca2 influx. These ob-
servations suggest that whether glycine and related
compounds indeed hold a therapeutic promise for neu-
ronal tissue damage in vivo remains to be investigated.
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